These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2526341)

  • 21. Plasma and urinary digitalis-like substance levels during atrial natriuretic peptide infusion in essential hypertensive patients.
    Baldoncini R; Ferri C; Bellini C; Desideri G; De Angelis C; Santucci A
    Clin Invest Med; 1996 Feb; 19(1):13-9. PubMed ID: 8868311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood levels and renal effects of atrial natriuretic peptide in normal man.
    Weidmann P; Hasler L; Gnädinger MP; Lang RE; Uehlinger DE; Shaw S; Rascher W; Reubi FC
    J Clin Invest; 1986 Mar; 77(3):734-42. PubMed ID: 2936762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma levels of atrial natriuretic peptide after exercise.
    Pasqualetti P; Casale R; Colantonio D
    Riv Eur Sci Med Farmacol; 1991; 13(3-4):115-9. PubMed ID: 1840332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circadian variation of plasma atrial natriuretic peptide, cortisol and fluid balance in the goat.
    Kokkonen UM; Riskilä P; Roihankorpi MT; Soveri T
    Acta Physiol Scand; 2001 Jan; 171(1):1-8. PubMed ID: 11350257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta-adrenoceptor blockade potentiates acute exercise-induced release of atrial natriuretic peptide by increasing atrial diameter in normotensive healthy subjects.
    Berlin I; Lechat P; Deray G; Landault C; Maistre G; Chermat V; Brouard R; Ressayre C; Puech AJ
    Eur J Clin Pharmacol; 1993; 44(2):127-33. PubMed ID: 8095894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The comparative beta-adrenoceptor blocking effects of penbutolol, atenolol and sustained-release metoprolol in healthy volunteers.
    Mucklow JC; Kuhn S
    Eur J Clin Pharmacol; 1984; 27(3):269-73. PubMed ID: 6510453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary ANP, ADH, and electrolyte excretion during saturation-excursion diving to pressures equivalent to 250 and 300 m.
    Tao HY; Chen HJ; Zhang H; Guo J; Rong FK
    Undersea Biomed Res; 1992 May; 19(3):159-69. PubMed ID: 1534426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long term treatment of moderate hypertension with penbutolol (Hoe 893d). I. Effects on blood pressure, pulse rate, catecholamines in blood and urine, plasma renin activity and urinary aldosterone under basal conditions and following exercise.
    Hansson BG; Hökfelt B
    Eur J Clin Pharmacol; 1975 Oct; 9(1):9-19. PubMed ID: 9298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tertatolol potentiates exercise-induced atrial natriuretic peptide release by increasing atrial diameter in healthy subjects.
    Berlin I; Deray G; Lechat P; Maistre G; Landault C; Chermat V; Brouard R; Ressayre C; Puech AJ
    Cardiology; 1993; 83 Suppl 1():16-24. PubMed ID: 7903211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes of circulating atrial natriuretic peptide and antidiuretic hormone in obstructive sleep apnea syndrome.
    Ichioka M; Hirata Y; Inase N; Tojo N; Yoshizawa M; Chida M; Miyazato I; Taniai S; Marumo F
    Respiration; 1992; 59(3):164-8. PubMed ID: 1439228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta-adrenoceptor blockade potentiates exercise-induced release of atrial natriuretic peptide.
    Deray G; Berlin I; Maistre G; Martinez F; Legrand S; Carayon A; Prost A; Puech A; Masson F; Legrand JC
    Eur J Clin Pharmacol; 1990; 38(4):363-6. PubMed ID: 1971599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Responses of antidiuretic hormone (ADH) and atrial natriuretic polypeptide (ANP) to hypertonic saline infusion in essential hypertensive patients and normotensive subjects].
    Miura F
    Nihon Naibunpi Gakkai Zasshi; 1992 Jan; 68(1):30-8. PubMed ID: 1531798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative beta-adrenoceptor blocking effects and pharmacokinetics of penbutolol and propranolol in man.
    Giudicelli JF; Richer C; Chauvin M; Idrissi N; Berdeaux A
    Br J Clin Pharmacol; 1977 Apr; 4(2):135-40. PubMed ID: 16632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of a fixed-dose combination of 40 mg penbutolol with 6 mg piretanide in the treatment of mild to moderate hypertension: a double-blind study against placebo.
    Yasky J; Verho M; Rangoonwala B
    Curr Med Res Opin; 1987; 10(6):397-406. PubMed ID: 3552458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cicletanine does not affect plasma atrial natriuretic peptide concentration in healthy subjects.
    Berlin I; Deray G; Maistre G; Masson F; Barthelemy C; Legrand JC; Jacobs C
    Eur J Clin Pharmacol; 1990; 39(6):593-4. PubMed ID: 1965645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the effects of penbutolol and propranolol on glomerular filtration rate in hypertensive patients with impaired renal function.
    van der Meulen J; Reijn E; Heidendal GA; Oe PL; Donker AJ
    Br J Clin Pharmacol; 1986 Oct; 22(4):469-74. PubMed ID: 3533129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A study of serum antidiuretic hormone and atrial natriuretic peptide levels in a series of patients with intracranial disease and hyponatremia.
    Weinand ME; O'Boynick PL; Goetz KL
    Neurosurgery; 1989 Nov; 25(5):781-5. PubMed ID: 2531299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacodynamic and pharmacokinetic study of oral and intravenous penbutolol.
    Vedin JA; Wilhelmsson C; Maass L; Peterson LE
    Eur J Clin Pharmacol; 1983; 25(4):529-34. PubMed ID: 6653649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Penbutolol: pharmacokinetics, effect on exercise tachycardia, and in vitro inhibition of radioligand binding.
    Brockmeier D; Hajdù P; Henke W; Mutschler E; Palm D; Rupp W; Spahn H; Verho MT; Wellstein A
    Eur J Clin Pharmacol; 1988; 35(6):613-23. PubMed ID: 2906875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.